Combining anticoagulants and antiplatelet drugs in coronary artery disease
An article in the latest edition of Australian Prescriber offers health professionals guidance when considering whether to combine anticoagulation and antiplatelet drugs in patients with coronary artery disease.
Authors Dr Jyotsna Janardan and Associate Professor Harry Gibbs, from Alfred Health in Melbourne, discuss whether it is safe to combine these drugs. They review the management of stable coronary artery disease and acute coronary syndrome.
Associate Professor Gibbs says, “The balance of harm and benefits depends on whether patients had stents inserted and if they have another indication for anticoagulation. The aim is to reduce cardiovascular events while minimising the risk of bleeding in these patients.”
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals. It is published by NPS MedicineWise, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health. Australian Prescriber is published every two months and is available online at nps.org.au/australianprescriber
Date published: 01 August 2018